RT Journal Article
SR Electronic
T1 Genomic epidemiology of early SARS-CoV-2 transmission dynamics in Gujarat, India
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.08.31.21262680
DO 10.1101/2021.08.31.21262680
A1 Raghwani, Jayna
A1 du Plessis, Louis
A1 McCrone, John T
A1 Hill, Sarah C.
A1 Parag, Kris V.
A1 Thézé, Julien
A1 Kumar, Dinesh
A1 Puvar, Apurva
A1 Pandit, Ramesh
A1 Pybus, Oliver G.
A1 Fournié, Guillaume
A1 Joshi, Madhvi
A1 Joshi, Chaitanya
YR 2021
UL http://medrxiv.org/content/early/2021/08/31/2021.08.31.21262680.abstract
AB Genomic surveillance of SARS-CoV-2 has played a decisive role in understanding the transmission and evolution of the virus during its emergence and continued circulation. However, limited genomic sampling in many high-incidence countries has impeded detailed studies of SARS-CoV-2 genomic epidemiology. Consequently, critical questions remain about the generation and global distribution of virus genetic diversity. To address this gap, we investigated SARS-CoV-2 transmission dynamics in Gujarat, India, during its first epidemic wave and shed light on virus’ spread in one of the pandemic’s hardest-hit regions. By integrating regional case data and 434 whole virus genome sequences sampled across 20 districts from March to July 2020, we reconstructed the epidemic dynamics and spatial spread of SARS-CoV-2 in Gujarat, India. Our findings revealed that global and regional connectivity, along with population density, were significant drivers of the Gujarat SARS-CoV-2 outbreak. The three most populous districts in Gujarat accounted ∼84% of total cases during the first wave. Moreover, we detected over 100 virus lineage introductions, which were primarily associated with international travel. Within Gujarat, virus dissemination occurred predominantly from densely populated regions to geographically proximate locations with low-population density. Our findings suggest SARS-CoV-2 transmission follows a gravity model in India, with urban centres contributing disproportionately to onward virus spread.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe sequencing work at GBRC was supported by Department of Science & Technology, Government of Gujarat. JR, GF, DK, AP, RP, OP, MJ, and CJ were supported by the UKRI GCRF One Health Poultry Hub (Grant No. BB/S011269/1). one of twelve interdisciplinary research hubs funded under the UK government's Grand Challenge Research Fund Interdisciplinary Research Hub initiative. SCH was supported by the Wellcome Trust [220414/Z/20/Z]. This research was funded in whole, or in part, by the Wellcome Trust [Grant number 220414/Z/20/Z]Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The studies involving human participants were reviewed and approved by the Institutional Ethical Committee of Gujarat Biotechnology Research Centre (GBRC) and respective government medical colleges. GBRC Gandhinagar B.J. Medical College and Civil hospital, Ahmedabad Banas Medical College and Research Institute, Palanpur Department of MicroBiology, Government Medical College, Surat Dr. N. D. Desai Medical College & Hospital, Nadiad Dr. RSS Hospital, Modasa GAIMS & G K General Hospital, Bhuj GMERS Medical College and Hospital, Gandhinagar GMERS Medical College and Hospital, Gotri, Vadodara GMERS Medical College and Hospital, Himmatnagar Government Medical College, Bhavnagar Government Medical College, Vadodara Pandit Deendayal Upadhyay Government Medical College, Rajkot Saikrishna Hospital, Mehsana Sardar Vallabhbhai Patel Institute of Medical Sciences & Research. Written informed consent to participate in this study was provided by the participants' legal guardian/next of kinAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in this study were collated from public databases and therefore are freely available. Regional case data, SARS-CoV-2 genome sequences and analysis files used in this study have been made available via https://github.com/jnarag/covid-gujarat. https://github.com/jnarag/covid-gujarat